(CercleFinance.com) – Mauna Kea Technologies announces the opening of the first Italian center of excellence for the use of Cellvizio in the identification and treatment of food intolerances in adult patients suffering from irritable bowel syndrome (IBS). ).
The Cellvizio Food Intolerance Test (C-FIT) is now in use at the UPMC Salvator Mundi International Hospital in Rome, making Italy the third country to open a Cellvizio Center of Excellence, after the United States and Italy. ‘Germany.
Mauna Kea highlights that the number of patients looking for solutions in food intolerance is particularly high in Italy, with more than a million Internet searches relating to this area per month, more than in Germany and France. .